Stratton E

Psychiatry, Sydney Medical School, https://ror.org/0384j8v12University of Sydney, Australia.

3 papers · ORCID

ArticleKetamine

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

Glozier N, Morris R, Stratton E +21

Europe PMC2026
ArticleKetamine

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Loo C, Glozier N, Barton D +35

Europe PMC2023
ArticleKetamine

A systematic review of the print media representation of ketamine treatments for psychiatric disorders.

Thornton NLR, Kawalsky J, Milton A +5

Europe PMC2023